FDA lays out 2010 advisory committee slate
This article was originally published in The Tan Sheet
Executive Summary
The agency's tentative 1schedule for advisory committee meetings includes a Food meeting May 20-21 and Pediatric sessions in March, June, September and December. FDA's calendar, published Dec. 30 in the Federal Register, also pencils in meetings for both the Risk Communication panel and Science Board in February, May, August and November. The Nonprescription Drug Advisory Committee has not had tentative or firm meeting dates set. NDAC last met in June 2009 for a joint session regarding acetaminophen with the Drug Safety and Risk Management and Anesthetic and Life Support Drugs committees (2"The Tan Sheet" July 6, 2009)
You may also be interested in...
NDAC meeting on calendar
FDA tentatively schedules a joint meeting of the Nonprescription Drug Advisory Committee and the Drug Safety and Risk Management Advisory Committee Sept. 14, the agency's Web site says. If the meeting is scheduled, the subject will not be known until FDA posts a Federal Register notice or updates meeting materials on its site. NDAC last met in June 2009, also with DSRM and the Life Support Drugs committee, to discuss acetaminophen (1"The Tan Sheet" Jan. 4, 2010, In Brief)
Acetaminophen OTC Combos Are Not Out Of The Woods, Despite Panel Vote
While FDA may not decide to discontinue all OTC products combining acetaminophen with other ingredients, manufacturers of combinations cannot assume all such products will avoid further scrutiny
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.